These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 4602094)

  • 1. Effects of heparin and of ALG with antiplatelet activity on blood and urinary histamine levels of humans with renal transplants.
    Moore TC; Lemmi CA
    Am Surg; 1974 Aug; 40(8):453-5. PubMed ID: 4602094
    [No Abstract]   [Full Text] [Related]  

  • 2. The mechanism behind the effect of ALG on platelets in vivo.
    Henricsson A; Husberg B; Bergentz SE
    Clin Exp Immunol; 1977 Sep; 29(3):515-22. PubMed ID: 589869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The nature of antiplatelet activity in antilymphoblast ALG--with special reference to cross-reacting antibody, immunochemical characterization, and Coombs' positive thrombocytopenia in ALG-treated renal recipients.
    Amemiya H; Yokoyama T; Putnam CW; Torisu M; Starzl TE
    Clin Exp Immunol; 1972 Mar; 10(3):417-26. PubMed ID: 4556008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early detection of canine renal allograft rejection by reduction in the scan bladder-kidney isotope intensity ratio.
    Hayes M; Moore TC
    Surgery; 1972 Jan; 71(1):60-5. PubMed ID: 4550236
    [No Abstract]   [Full Text] [Related]  

  • 5. Elevation in urinary and blood histamine following clinical renal transplantation.
    Moore TC; Thompson DP; Glassock RJ
    Ann Surg; 1971 Mar; 173(3):381-8. PubMed ID: 4101117
    [No Abstract]   [Full Text] [Related]  

  • 6. Platelet-induced donor-specific unresponsiveness to kidney allografts in mongrel dogs treated with ALG.
    Rowinski W; Ryffa T; Ruke M; Wasowska B; Tilney NL; Olszewski WL
    Transplant Proc; 1981 Mar; 13(1 Pt 1):586-8. PubMed ID: 6168052
    [No Abstract]   [Full Text] [Related]  

  • 7. Antilymphocyte globulin (ALG) reverses "irreversible" allograft rejection.
    Light JA; Alijani MR; Biggers JA; Oddenino K; Reinmuth B
    Transplant Proc; 1981 Mar; 13(1 Pt 1):475-81. PubMed ID: 7022877
    [No Abstract]   [Full Text] [Related]  

  • 8. [Non-HL-A specific anti-thrombocyte autoantibodies in patients after kidney transplantation].
    Kuster J; Binswanger U; von Felten A
    Schweiz Med Wochenschr; 1976 Oct; 106(40):1376. PubMed ID: 795024
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Improvement of the results of renal transplantation by the use of antilymphocyte globulin (ALG)].
    Renna E; Alfani D; Monari C; Trovati A; Berloco P; Famulari A; Cucchiara G; Cortesini R
    Minerva Chir; 1980 May; 35(10):747-50. PubMed ID: 7005730
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical aspects of allograft rejection.
    Williams GM
    Transplant Proc; 1974 Dec; 6(4 Suppl 1):71-7. PubMed ID: 4612907
    [No Abstract]   [Full Text] [Related]  

  • 11. Bone marrow function during quadruple immunosuppressive therapy after renal transplantation.
    Heaf J
    Clin Nephrol; 1993 Dec; 40(6):332-8. PubMed ID: 8299241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of platelets and lymphocytes for the hemodynamic effects of rapidly injected antilymphocyte globulin.
    Henricsson A; Bergentz SE
    Eur Surg Res; 1978; 10(1):40-9. PubMed ID: 631148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelet complement fixation: an in vitro test of the immunosuppressive activity of antilymphocyte globulin.
    Balfour IC; Pegrum GD; Williams GB; Balner H
    Transplantation; 1972 Sep; 14(3):308-10. PubMed ID: 4629282
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical experience with antilymphocyte globulin (ALG) in renal transplantation.
    Deodhar SD; Konomi K; Nakamoto S; Kuruvila KC
    Transplant Proc; 1971 Mar; 3(1):758-61. PubMed ID: 4937968
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of prophylaxis with low-dose anti-thymocyte globulin on prevention of acute kidney allograft rejection.
    Khosroshahi HT; Tubbs RS; Shoja MM; Ghafari A; Noshad H; Ardalan MR
    Transplant Proc; 2008; 40(1):137-9. PubMed ID: 18261569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Description of kidney transplant function during first year.
    Transplantation; 1969 Nov; 8(5):728-38. PubMed ID: 4928432
    [No Abstract]   [Full Text] [Related]  

  • 17. Outcome of live-related donor renal transplants in their second decade.
    Georgi BA; Cacciarelli TV; Sumrani N; Goldberg K; Hong JH; Sommer BG
    Transplant Proc; 1993 Jun; 25(3):2164-5. PubMed ID: 8516853
    [No Abstract]   [Full Text] [Related]  

  • 18. [The complement system in experimental and clinical kidney transplantation (author's transl)].
    Kux M
    Wien Klin Wochenschr; 1974 Jan; 86(2):29-39. PubMed ID: 4613019
    [No Abstract]   [Full Text] [Related]  

  • 19. The role of heparin in prolonging acute renal ischemia time.
    Fegen JP; Albert DJ; Persky L
    Invest Urol; 1971 Jul; 9(1):16-20. PubMed ID: 5563423
    [No Abstract]   [Full Text] [Related]  

  • 20. Acute rejection episodes after renal transplantation in children.
    Hoyer PF; Offner G; Brodehl J
    Clin Nephrol; 1983 Feb; 19(2):61-6. PubMed ID: 6340876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.